Biography
Dr. Matthew A. Gubens is an Associate Professor of Medicine at UCSF and the primary mesothelioma medical oncologist at the Helen Diller Family Comprehensive Cancer Center in San Francisco. He completed his medical degree at Harvard Medical School and his fellowship at UCSF, and holds an MS in Clinical Research. Dr. Gubens specializes in systemic therapy for malignant pleural mesothelioma, offering patients on the West Coast access to the latest chemotherapy and immunotherapy regimens as well as clinical trial opportunities at one of the nation's leading NCI-designated comprehensive cancer centers.
Education & Training
- Medical Degree — Harvard Medical School (Medicine)
- MS — University of California, San Francisco (Clinical Research)
- Residency — Massachusetts General Hospital (Internal Medicine)
- Fellowship — UCSF (Hematology/Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
As a medical oncologist, Dr. Matthew A. Gubens focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Systemic therapy for malignant pleural mesothelioma, immunotherapy approaches for thoracic cancers, and clinical trial development.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Is Dr. Gubens the primary mesothelioma oncologist at UCSF?
Yes. Dr. Gubens is the primary medical oncologist for mesothelioma patients at UCSF Helen Diller Family Comprehensive Cancer Center, providing systemic therapy and clinical trial access within a multidisciplinary thoracic oncology team.